A detailed history of Engineers Gate Manager LP transactions in Erasca, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 34,523 shares of ERAS stock, worth $89,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,523
Holding current value
$89,069
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$1.36 - $2.18 $46,951 - $75,260
34,523 New
34,523 $75,000
Q4 2022

Feb 14, 2023

BUY
$3.89 - $8.57 $93,391 - $205,748
24,008 New
24,008 $103,000

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $315M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.